Today: 9 June 2026

Roman Perkowski

Rigetti Computing Stock Jumps Before RGTI Earnings as Quantum Revenue Test Hits Tonight

Rigetti Shares Fall Premarket With Fresh Nasdaq Test for Quantum

Rigetti Computing shares dropped 10.4% to $24.10 in pre-market trading as investors brace for Quantinuum’s $1.68 billion Nasdaq IPO, signaling a sector-wide markdown in quantum stocks driven by competitive pressure, funding uncertainty, and continued operating losses despite recent government R&D agreements and strong investor appetite for quantum assets.
Archer Aviation trades under $7 as next test looms for air-taxi gamble

Archer Aviation trades under $7 as next test looms for air-taxi gamble

Archer Aviation shares dipped below $7 premarket after closing at $6.74, as investors weigh heavy cash burn—$217.7 million Q1 net loss, $1.78 billion cash on hand—against hopes for first U.S. eVTOL flights this year; Cantor Fitzgerald cut its price target to $11 but kept an Overweight rating, while 46 disclosed risks and ongoing certification challenges cloud near-term outlook.
Rigetti moves up, but new filings keep quantum trades on edge

Rigetti moves up, but new filings keep quantum trades on edge

Rigetti Computing shares jumped 4.9% to $26.88, boosting its market value to $9.0 billion as insider filings showed CEO Subodh Kulkarni and CTO David Rivas sold shares after option exercises, while investors weighed a proposed $100 million Commerce Department funding deal that could speed up R&D but may dilute shareholders if finalized; the company posted Q1 revenue of $4.4 million and an operating loss of $26.0 million.
US stocks notch new highs with AI trade still in focus

Wall Street Record Faces Latest Test After Hours: AI Hype, Oil, Rates, Jobs Collide

Hewlett Packard Enterprise soared after a strong quarter put it on track to hit long-term financial targets two years early, fueling gains in AI hardware stocks and driving the Philadelphia SE Semiconductor Index up 5.9%, even as after-hours trading stayed cautious and software names lagged.
Amazon Gets June Prime Day Announcement, Stock Falls

Amazon Gets June Prime Day Announcement, Stock Falls

Amazon shares slid 1.81% to $256.52 even as it set June 23-26 for Prime Day, giving investors an early look at retail momentum before Q2 ends; despite strong AWS growth and rising net sales, free cash flow fell as AI investments surged, leaving investors cautious about whether Prime Day’s grocery push and earlier timing will boost margins or just shift demand.
Coherent Corp Stock: BofA’s $400 Call Puts AI Optics Back in Play

Coherent Stock Is Surging Again — Here’s Why Wall Street Is Chasing AI’s Hidden Bottleneck

Coherent shares soared 17% to $425.44 after strong Q3 results and renewed AI infrastructure demand, fueled by Nvidia’s $2 billion March investment and fresh focus on supply bottlenecks; the company guided Q4 revenue as high as $2.05 billion, but risks remain if AI spending or Nvidia-linked demand falters.

Stock Market Today

  • J.M. Smucker Shares Rise After Earnings Beat Despite Sales Warning
    June 9, 2026, 10:05 AM EDT. J.M. Smucker shares rose 3.16% in pre-market trading after the company reported a 20% rise in adjusted earnings per share to $2.77, beating Wall Street estimates. The packaged-food firm grew net sales by 6% to $2.27 billion in Q4 but issued a cautionary note, forecasting a 3-4% decline in annual sales for fiscal 2027, below analysts' expectations of 1% growth. CEO Mark Smucker highlighted a focus on organic volume growth and profit improvement amid shifts in industry pricing strategies. Coffee sales drove quarterly results with a 12% retail sales increase but volume declines. The company flagged risks including consumer shifts to store brands, weight-loss drug impacts, and tariff fluctuations. Smucker's outlook balances lower sales with improved profitability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop